RxDoctor Payments Data

Herschel Vargas, MD

Colon & Rectal Surgery · New Orleans, LANPI 1376507418

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,543 of the $2,337 with a category attached, or 66.0%. 8 manufacturers reported payments, led by Intuitive Surgical at 42.4% of the total. Reporting peaked in 2019 at $1,229 and has fallen 97.1% since, to $36 in 2025. That places this record below the midpoint for colon & rectal surgery clinicians in LA, where the typical reported total is $4,339.

$2,337in general payments, 2019–2025

Across 24 payments — averaging $97.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$992
  • Davol Inc.$463
  • Medtronic$233
  • Biom'up France SAS$228
  • Kerecis Limited$151
  • Biom'up SA$150
  • plus $121 from 2 others
$13,055in research payments, 2019–2025

Across 20 payments — averaging $652.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceuticals U.S.A., Inc.$10K
  • Shire North American Group Inc$3K

What the payments were for

  • Travel & lodging$79434%
  • Food & beverage$1,54366%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,337 in reported general payments places this provider in the 40th percentile of 39 colon & rectal surgery providers in Louisiana.

See all colon & rectal surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$56,261
Medicare patients
179
Services billed
328

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates26$1,667
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl51$787
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl40$657
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl14$244
Mupirocin18$112
Oxycodone Hcl22$80
Chlorhexidine Gluconate19$62

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →